• Five Trends Impacting Global Health in 2018

    by Michael Fronstin  |  Sep 24, 2018
    Kantar Health's Global Health and Wellness Report remains the world's most comprehensive, patient-centric examination of global healthcare – providing unique insights on the most pressing health challenges facing the United States, the EU5, Japan, and the key healthcare growth markets of China, Brazil and Russia.
  • Think You Know India?

    by Gauri Pathak  |  Sep 21, 2018
    As the second most populous country in the world, India faces a wide variety of health challenges across its diverse demographics. For pharma companies to achieve commercial success, a local presence and a comprehensive understanding of the Indian market nuances are a must for developing and executing a highly informed market access strategy.
  • Checking All the Boxes

    by Jessica Santos  |  Sep 18, 2018
    Navigating through compliance issues and regulatory mazes when designing a patient study is undoubtedly difficult, but success can be more easily achieved through a well-conceived, high-quality approach.
  • GDPR: Protecting Patient Privacy in Europe

    by Jessica Santos  |  Aug 22, 2018
    Having taken effect in May 2018, the GDPR imposes new obligations on organizations that process the personal data of EU residents, including research agencies, pharmaceutical manufacturers and data analytic companies.
  • Eureka Moments!

    by Richard Goosey  |  Aug 17, 2018
    The revolutionary new uses of the “share of preference” measurement is a eureka moment in marketing science for the pharmaceutical industry. Combined with a brand’s existing market share, share of preference can now be used to look at where a brand’s market share currently stands, where it could rise to, and most importantly how to get there by pulling the lever and minimizing the impact of barriers!
More than one Google Analytics scripts are registered. Please verify your pages and templates.